The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of NSCLC patients with acquired RET rearrangement after resistance to osimertinib.
 
Chang Lu
No Relationships to Disclose
 
Jia-Tao Cheng
No Relationships to Disclose
 
Jin Kang
No Relationships to Disclose
 
Yi-Hui Yao
No Relationships to Disclose
 
Xiang-Meng Li
No Relationships to Disclose
 
Xuchao Zhang
No Relationships to Disclose
 
Qing Zhou
No Relationships to Disclose
 
Hai-Yan Tu
No Relationships to Disclose
 
Yi-Long Wu
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Roche
Research Funding - Boehringer Ingelheim (Inst); Roche (Inst)
 
Jin-Ji Yang
No Relationships to Disclose